Giardia antibody and antigen (recombinant protein)

Diagnostic anti-Giardia antibodies pairs and antigen for animal health (animal Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Equine/Horse, Ovines/Sheep, Caprine/Goat, Fish, Swine/Porcine/Pig, Avian/Bird/Poultry infectious disease Giardiasis) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Multiple species disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P237-Ag01 Recombinant Giardia protein $3090.00
GMP-VT-P237-Ab01 Anti-Giardia mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P237-Ab02 Anti-Giardia mouse monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P237-Ag01
Product Name Recombinant Giardia protein
Pathogen Giardia
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Giardia antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Giardia level test of animal Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Equine/Horse, Ovines/Sheep, Caprine/Goat, Fish, Swine/Porcine/Pig, Avian/Bird/Poultry infectious disease with Giardiasis.
Tag His
Product description Recombinant Giardia proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P237-Ab01,GMP-VT-P237-Ab02
Pathogen Giardia
Product Name Anti-Giardia mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Giardia antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Giardia antibodies in Giardia level test of animal Cat/Feline, Dog/Canine, Rabbit, Bovines/Cattle, Equine/Horse, Ovines/Sheep, Caprine/Goat, Fish, Swine/Porcine/Pig, Avian/Bird/Poultry infectious disease with Giardiasis.
Product description Anti-Giardia mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Giardia antibodies./td>
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Pathogen


    Giardia intestinalis (also known as G. lamblia) is a unicellular parasite that belongs to the phylum Diplomonadida. It is found worldwide and causes an infection known as giardiasis, which affects millions of people annually. The parasite has a unique morphology and a complex life cycle that allows it to successfully colonize the small intestine of its host.

    Giardia is a eukaryotic microorganism, meaning that it has a membrane-bound nucleus and other membrane-bound organelles such as endoplasmic reticulum and mitochondria. Despite being eukaryotic, Giardia also has some characteristics of prokaryotic organisms, such as a lack of canonical mitosis and the presence of two nuclei per cell.

    The morphology of Giardia intestinalis is characterized by the presence of two nuclei, eight flagella, and a ventral adhesive disc. The flagella function in motility, enabling the parasite to swim and migrate through the host's intestine. The adhesive disc serves as a structure for attachment to the host's intestinal cells, allowing the parasite to avoid being expelled from the body through the feces.

    Giardiasis, caused by Giardia infection, is one of the most common parasitic infections in humans worldwide. The symptoms of giardiasis include diarrhea, abdominal pain, and weight loss, and can last for several weeks if left untreated. In severe cases, the infection can lead to dehydration and malabsorption of nutrients.

    One of the key aspects of diagnosing giardiasis is identifying the presence of Giardia cysts or trophozoites in a stool sample. Stool examination can be done using direct microscopy, immunological assays, or nucleic acid detection techniques such as PCR. Immunological assays target antigens specific to Giardia, while PCR techniques can detect small amounts of Giardia DNA in fecal samples.

    The genome of Giardia has been sequenced and its potential proteins, including virulence factors, have been identified. The main genetic component for Giardia is the beta-giardin gene, which is involved in the formation of the actin-rich cytoskeleton and attachment of the parasite to the intestinal lining. Meanwhile, giardin is the main protein involved in cytoskeletal organization and attachment.

    In terms of treatment, the standard course of treatment for giardiasis is the use of either metronidazole or tinidazole. These antibiotics work by disrupting DNA synthesis in the parasite and therefore killing it. However, resistance to these antibiotics has emerged, and new drugs are being developed to target Giardia.

    Overall, Giardia is an important pathogenic organism that poses a significant public health problem due to its widespread presence and ability to cause infection in humans and other animals. A better understanding of the biology of this unique microorganism could lead to improved diagnostics and treatments for giardiasis, ultimately reducing the global burden of disease caused by this parasite.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.